Subspecialties: Page 44

ISMRM: Insulin resistance in women associated with less myelin, changes in brain
By Maryam Payne
ISMRM research indicates that higher insulin resistance is associated with less myelin in women.
May 10, 2025
Associations between insulin resistance and MWF. (A) Distribution of insulin resistance, stratified by sex. (B) Regression analysis of whole-brain MWF vs. log (HOMA-IR), adjusted for age and age². Shaded regions indicate 95% confidence intervals. (C) Regression analysis of whole-brain MWF vs. log (HOMA-IR), adjusted for age, age², sex, and log (HOMA-IR) sex. Graphics and caption courtesy of Nathan Zhang, PhD, and the ISMRM.
Alzamend Neuro adds partners for lithium study using specialty head coil
By AuntMinnie.com staff writers
Tesla coil key component of the clinical study.
May 9, 2025
Circuit board sculpture of a robotic head with electronic components
Covera Health expanding COE program to prostate imaging
By AuntMinnie.com staff writers
Covera Health is adding prostate imaging to its Radiology Centers of Excellence (COE) platform.
May 8, 2025
Prostate Cancer 3 D Rendering 400 (1)
CNN techniques outperform conventional DL for Alzheimer's diagnosis
By Kate Madden Yee
Convolutional neural network (CNN) techniques outperform conventional deep learning (DL) methods in diagnosing Alzheimer's.
May 7, 2025
Alzheimers Amyloid
Cleerly, Cardiac Care Alliance partner on cardiac assessment
By AuntMinnie.com staff writers
Cleerly and Cardiac Care Alliance will collaborate on offering Cleerly's coronary artery disease assessment technology.
May 6, 2025
Cardiac Heart Eeg
PET/MRI and DECT show abnormalities in long COVID patients
By Will Morton
Patients with long COVID show lung and heart abnormalities on PET/MRI and dual-energy CT imaging.
May 5, 2025
Cardiac MRI scans with color-coded heat maps showing heart tissue analysis
RaySearch launches v2025 RayStation
By AuntMinnie.com staff writers
The company is highlighting the integration of the autoplanning algorithm ECHO.
May 2, 2025
RaySearch Laboratories logo displayed on large blue gradient screen at tech event
ARRS: Get involved with breast health advocacy
By Amerigo Allegretto
At ARRS 2025, Amy Patel, MD, discussed the need for advocacy to drive legislation on insurance coverage for women with dense breasts.
May 2, 2025
In her ARRS 2025 presentation, Amy Patel, MD, discussed ways that radiologists can be proactive in influencing legislation that addresses breast density. These include working with elected officials and joining medical societies, among others.
ARRS: The state of lung imaging
By Kate Madden Yee
There are a number of options for lung nodule imaging, and which to use depends on the patient.
May 1, 2025
Medical X-ray of human lungs showing respiratory system anatomy
ARRS: Most women under 40 have no imaging before breast cancer diagnosis
By Amerigo Allegretto
Most young women who are diagnosed with breast cancer had no prior imaging performed.
May 1, 2025
Breast cancer research results comparing receptor status and surgical treatments across two cohorts
AANS: AI shows accuracy in aneurysm detection
By Maryam Payne
A commercial AI application was highly accurate in detecting intracranial aneurysms on over 11,000 CT angiography studies.
April 30, 2025
Digital brain on circuit board representing AI and neural technology
Preop MRI fails to deliver results for breast cancer subtype
Preoperative MRI didn't improve outcomes in women with HER2-positive and hormone receptor-negative breast cancer in a new study.
April 29, 2025
Images show a palpable mass in the left breast in a 55-year-old woman. (A) Mammography shows a 26-mm ill-defined mass with fine linear calcifications in the central portion of the left breast (arrows). (B) ultrasound shows a 23-mm hypoechoic mass with calcifications in the corresponding area accompanying palpability (between the arrows). (C) An axial, fat-saturated, contrast-enhanced T1-weighted MRI scan shows an 18-mm irregular heterogeneous enhancing mass in the left breast (arrows). After breast-conserving surgery, the final pathologic report confirmed a grade II estrogen receptor–negative, progesterone receptor–negative, human epidermal growth factor receptor 2–positive invasive ductal carcinoma. There was no lymphovascular invasion, and the resection margins were clear. The patient declined both adjuvant chemotherapy and radiation therapy due to psychologic distress. (D) 11 months later, surveillance ultrasound helped to detect a new 25-mm irregular hypoechoic mass at the 12-o’clock position in the left breast (arrows). A subsequent ultrasound-guided biopsy confirmed it as a recurrence of grade II invasive ductal carcinoma, maintaining the same receptor statuses. Images courtesy of the RSNA.
Previous Page
Page 44 of 1582
Next Page